| 2026-03-17 |
详情>>
股本变动：
变动后总股本2966.39万股
|
| 2026-03-17 |
详情>>
业绩披露：
2025年年报每股收益-0.9美元,归母净利润-2554万美元,同比去年增长-35.03%
|
| 2026-03-17 |
财报披露：
美东时间 2026-03-17 盘后发布财报
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.63美元,归母净利润-1775.4万美元,同比去年增长-31.24%
|
| 2025-08-12 |
详情>>
业绩披露：
2025年中报每股收益-0.42美元,归母净利润-1186.3万美元,同比去年增长-38.68%
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.22美元,归母净利润-602.6万美元,同比去年增长-45.34%
|
| 2025-04-09 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the eight directors named herein to serve until the 2026 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers;
4.Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation. To cast an advisory (non-binding) vote to set the frequency of future advisory (non-binding) votes to approve the compensation of our named executive officers;
5.Approval of our Amended and Restated 2021 Employee Stock Purchase Plan. To approve our Amended and Restated 2021 Employee Stock Purchase Plan (the “ESPP”);
6.Approval of our Sixth Amended and Restated 2013 Incentive Compensation Plan. To approve our Sixth Amended and Restated 2013 Incentive Compensation Plan;
7.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益-0.7美元,归母净利润-1891.4万美元,同比去年增长14.37%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.5美元,归母净利润-1352.8万美元,同比去年增长22.56%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-0.32美元,归母净利润-855.4万美元,同比去年增长32.44%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.16美元,归母净利润-414.6万美元,同比去年增长26.08%
|
| 2024-04-05 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the eight directors named herein to serve until the 2025 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers;
4.Approval of our Fifth Amended and Restated 2013 Incentive Compensation Plan. To approve our Fifth Amended and Restated 2013 Incentive Compensation Plan;
5.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益-0.9美元,归母净利润-2208.9万美元,同比去年增长-34.4%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.71美元,归母净利润-1747万美元,同比去年增长-44.98%
|
| 2023-04-14 |
股东大会：
将于2023-05-24召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the eight directors named herein to serve until the 2024 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers;
4.Approval of an Amendment to our Amended and Restated Certificate of Incorporation. To approve an amendment to our Amended and Restated Certificate of Incorporation to reduce the number of authorized shares of common stock from two hundred million (200,000,000) shares to ninety million (90,000,000) shares;
5.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2022-04-11 |
股东大会：
将于2022-05-24召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the eight directors named herein to serve until the 2023 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers;
4.Approval of our Fourth Amended and Restated 2013 Incentive Compensation Plan. To approve our Fourth Amended and Restated 2013 Incentive Compensation Plan;
5.Approval of an amendment to our Amended and Restated Certificate of Incorporation. To approve an amendment to our Amended and Restated Certificate of Incorporation to reduce the number of authorized shares of common stock from two hundred million (200,000,000) shares to eighty million (80,000,000) shares;
6.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-19 |
股东大会：
将于2021-06-03召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the six directors named herein to serve until the 2022 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.Approval of our Employee Stock Purchase Plan. To approve our Employee Stock Purchase Plan;
4.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers;
5.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2020-04-20 |
股东大会：
将于2020-06-02召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the nine directors named herein to serve until the 2021 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.Approval of our Third Amended and Restated 2013 Incentive Compensation Plan. To approve our Third Amended and Restated 2013 Incentive Compensation Plan;
4.Advisory Approval of Executive Compensation. To cast an advisory (non-binding) vote to approve the compensation of our named executive officers; 5.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2019-11-07 |
详情>>
内部人交易：
BURNETT JOSEPH MICHAEL股份减少5590.00股
|
| 2019-04-16 |
股东大会：
将于2019-06-30召开股东大会
会议内容 ▼▲
- 1.Election of our Directors. To elect the six directors named herein to serve until the 2020 Annual Meeting of Stockholders;
2.Ratification of the Auditors. To ratify the selection of Cherry Bekaert LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.Other Business. To transact such other business as may properly come before the Annual Meeting or any adjournment of the meeting.
|
| 2016-06-06 |
股东大会：
将于2016-06-30召开股东大会
会议内容 ▼▲
- 1. To approve an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of common stock at a ratio of 1-for-15, 1-for-20, 1-for-25, 1-for-30, 1-for-35 or 1-for-40, with the specific ratio and effective time of the reverse stock split to be determined by our Board of Directors (Proposal 1);
2. To approve one or more adjournments to the Special Meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting cast in favor of Proposal 1 (Proposal 2);
3. To transact such other business as may properly come before the Special Meeting or any adjournment or postponement thereof.
|